中国药物警戒 ›› 2012, Vol. 9 ›› Issue (4): 218-221.

• 管理及工作研究 • 上一篇    下一篇

儿童退热药风险干预研究

张昊，赵频，武志昂*   

  1. 沈阳药科大学工商管理学院，辽宁 沈阳 110016
  • 收稿日期:2011-12-14 出版日期:2012-04-10 发布日期:2015-08-10
  • 通讯作者: 武志昂,男,博士,主任药师,药品技术评价,药品风险管理。E-mail:wuzhiang@cdr.gov.cn
  • 作者简介:张昊，男，博士在读，药品不良反应监测。

A Research on the Risk of Intervention in Antipyretics for Children

ZHANG Hao, ZHAO Pin, WU Zhi-ang*   

  1. College of Business Administration, Shenyang Pharmaceutical University,Liaoning Shenyang 110016, China
  • Received:2011-12-14 Online:2012-04-10 Published:2015-08-10

PDF (PC)

203

摘要： 介绍了我国儿童退热药的种类、使用情况及其不良反应，并对儿童用药的风险来源进行分析。经查阅美国食品药品监督局及欧洲药品评价局等官方网站，得出欧美等国关于儿童药物的注册方案及不良反应的干预措施。最后提出降低小儿退热药用药风险的相关建议，以促进我国小儿退热药的安全使用。

关键词: 儿童退热药, 风险来源, 干预措施

Abstract: This paper describes the varieties, usage situations and adverse reactions of Antipyretics for children and analyses the sources of risk of the drugs for children. The registration schemes and interventions in the adverse reactions of drugs for children in USA and Europe have been concluded by scanning the official websites of FDA and EMEA. At the end of the paper, the advice related with the risk of antipyretic for children are brought up to contribute to safe use of antipyretics for children in China.

Key words: antipyretics for children, sources of risk, intervention